[The evolution of nursing careers, between hope and disillusionment]. / L'évolution des carrières infirmières, entre espoirs et désillusions.

The onset of the pandemic has exhausted and disenchanted most hospital professionals. It also seems to have accelerated awareness within the nursing group, particularly among the new "mastered" staff. Working conditions continue to deteriorate and career promises seem to be eroding. Yet in the late 2010s, spokespersons for the nursing occupational group were congratulating themselves on their latest victories. So what happened in such a short time?

What role does the general practitioner in France play among cancer patients during the initial treatment phase with intravenous chemotherapy? A qualitative study.

BACKGROUND: France's ethical and legal principles place general practitioners (GPs) at the forefront of cancer patient management, coordination, and follow-up. The objective of this study was to determine the actual role of GPs in the follow-up phase as well as patient perspectives on their GPs. METHOD: A multidisciplinary group of researchers conducted this qualitative study based on in-depth interviews of 50 patients managed at two cancer centres. A content analysis method was used to analyse the study data. RESULTS: According to the patients interviewed for this study, their GPs were relatively ineffective at managing medical problems related to cancer by comparison with their oncologists. Nonetheless, the patients had all consulted their GPs during the interval between the diagnosis and our interview. Reasons given for consulting their GPs included administrative matters, psychological support, reassurance, and advice, but also to a lesser extent, medical management. CONCLUSION: Patients' perspectives called attention to two aspects of the role of GPs in the French healthcare system: (a) the importance of GPs within an effective system for managing cancer patients, and (b) for some patients, GPs' relative lack of medical skill compared to oncologists.

[Healthcare democracy and society's challenges with regard to medicines]. / Démocratie sanitaire et enjeux de société autour des médicaments.

France is particularly concerned by high levels of drug prescriptions. This over-prescription can be further amplified by possible ties with pharmaceutical companies. However, it can be moderated bythe influence of healthcare professionals, including nurses. All these factors must be considered while taking into account the patient's best interests.